Astonea Labs IPO Subscribed 1.79x on Day 3

Astonea Labs IPO subscribed over 1.79x on its Last day of subscription, wherein QIB subscribed 0.70x, NII subscribed 5.60x, and RII subscribed 1.69x.

Astonea Labs IPO subscription started on Tuesday, May 27, 2025, and will close on Thursday, May 29, 2025, as per the schedule. The price band is set at ₹128 to ₹135 per share with a face value of ₹10. 

Astonea Labs IPO Subscription Status

Astonea Labs IPO subscribed over 1.79x on its Last day till 05.00 PM on 29th May 2025.

  • Astonea Labs IPO subscription QIB investors portion is 0.70x times, while NII subscribed 5.60x times, and RII investors subscribed 1.69x times.
  • The company has received bids for 47,27,000 shares against 26,46,000 shares on offer on the Last day.
  • Astonea Labs IPO subscribed over 0.64x on day 2.
  • Astonea Labs IPO subscribed over 0.22x on day 1.

About Astonea Labs IPO 

Astonea Labs Ltd is a trusted manufacturing company and has over 35 years of experience in the industry. It’s based in Haryana, India. They are proud of their strong focus on customer satisfaction and ability to offer flexible manufacturing solutions that help clients grow and succeed. They work mainly as a quality-focused third-party manufacturer, producing a wide range of pharmaceutical and cosmetic products. These include tablets, capsules, softgels, powders, ointments, creams, and lotions, all made to meet strict Drug and Cosmetics industry standards. Astonea Labs’ goal is to consistently provide high-quality products that support and improve the lives of people around the world.

Astonea Labs IPO Company Financial Report

The company reported revenue of ₹80.29 crores in 2024 against ₹67.26 crores in 2023. The company reported a profit of ₹3.81 crores in 2024 against a profit of ₹0.67 crores in 2023.

Astonea Labs IPO GMP:

Astonea Labs IPO GMP was ₹0 as of Thursday, 29th May 2025. That indicates the IPO is trading at ₹135 with a ₹0 premium in the grey market against the issue price of ₹135.

Share the Post:
Facebook
Twitter
LinkedIn

Leave a Reply

Your email address will not be published. Required fields are marked *